The Patent Finder

Forest Laboratories Holdings Limited

15 patents currently held · Updated Nov 21, 2026
24 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

9
Ending by 2030
Oct 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 23, 2026
    The maintenance fee for Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt (US 9,062,053) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.
  • 1 fee due Jun 29, 2027
    The maintenance fee for Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds (US 9,221,821) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
  • 1 fee due Aug 16, 2027
    The maintenance fee for Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide (US 9,259,403) comes due Aug 16, 2027. Unpaid by Feb 16, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 3 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,838,552Compositions Comprising Nebivolol
In force
 · High confidence
In forceHigh confidence
US 8,227,623Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
In force
 · High confidence
In forceHigh confidence
US 7,750,167Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
In force
 · High confidence
In forceHigh confidence
US 7,964,739Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
In force
 · High confidence
In forceHigh confidence
US 8,288,553Method for preparing disubstituted piperidine and intermediates
In force
 · USPTO record
In forceUSPTO record
US 9,629,861Compositions and methods for treating bacterial infections using ceftaroline
In force
 · USPTO record
In forceUSPTO record
US 9,062,053Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt
In force
 · High confidence
In forceHigh confidence
US 9,580,424Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt
In force
 · High confidence
In forceHigh confidence
US 9,259,403Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide
In force
 · USPTO record
In forceUSPTO record
US 8,247,400Cephem compounds useful for the treatment of bacterial infections
In force
 · USPTO record
In forceUSPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
Also on record, not counted in the 15: 24 patents in force now held by others · 26 lapsed for an unpaid fee · 37 ended at full term · 2 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 31 abandoned · 90 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited